Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Circulating serum microRNA (miR-367-3p, miR-371a-3p, miR-372-3p, miR-373-3p) as biomarkers for patients with testicular germ cell cancers.

Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J.

J Urol. 2014 Jul 18. pii: S0022-5347(14)03957-3. doi: 10.1016/j.juro.2014.07.010. [Epub ahead of print]

PMID:
25046619
[PubMed - as supplied by publisher]
2.

Increased DNA integrity in colorectal cancer.

Leszinski G, Lehner J, Gezer U, Holdenrieder S.

In Vivo. 2014 May-Jun;28(3):299-303.

PMID:
24815830
[PubMed - in process]
3.

Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.

Gezer U, Holdenrieder S.

In Vivo. 2014 May-Jun;28(3):287-92.

PMID:
24815828
[PubMed - in process]
4.

Novel serum nucleosomics biomarkers for the detection of colorectal cancer.

Holdenrieder S, Dharuman Y, Standop J, Trimpop N, Herzog M, Hettwer K, Simon K, Uhlig S, Micallef J.

Anticancer Res. 2014 May;34(5):2357-62.

PMID:
24778043
[PubMed - indexed for MEDLINE]
5.

miR-141 and miR-375 induction and release are different from PSA mRNA and PCA3 upon androgen stimulation of LNCaP cells.

Tiryakioglu D, Bilgin E, Holdenrieder S, Dalay N, Gezer U.

Biomed Rep. 2013 Sep;1(5):802-806. Epub 2013 Jul 15.

PMID:
24649032
[PubMed]
Free PMC Article
6.

Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study.

Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, Kristiansen G, Müller SC, Ellinger J.

Anticancer Res. 2014 Feb;34(2):665-9.

PMID:
24510997
[PubMed - indexed for MEDLINE]
7.

Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases.

Denk G, Omary AJ, Reiter FP, Hohenester S, Wimmer R, Holdenrieder S, Rust C.

Hepatol Res. 2014 Jan 23. doi: 10.1111/hepr.12304. [Epub ahead of print]

PMID:
24451045
[PubMed - as supplied by publisher]
8.

Diagnostic relevance of plasma DNA and DNA integrity for breast cancer.

Stötzer OJ, Lehner J, Fersching-Gierlich D, Nagel D, Holdenrieder S.

Tumour Biol. 2014 Feb;35(2):1183-91. doi: 10.1007/s13277-013-1158-4. Epub 2013 Sep 10.

PMID:
24018822
[PubMed - indexed for MEDLINE]
9.

Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy.

Lehner J, Stötzer OJ, Fersching D, Nagel D, Holdenrieder S.

Clin Chim Acta. 2013 Oct 21;425:206-11. doi: 10.1016/j.cca.2013.07.027. Epub 2013 Aug 2.

PMID:
23916787
[PubMed - indexed for MEDLINE]
10.

Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.

Wittwer C, Boeck S, Heinemann V, Haas M, Stieber P, Nagel D, Holdenrieder S.

Int J Cancer. 2013 Dec 1;133(11):2619-30. doi: 10.1002/ijc.28294. Epub 2013 Aug 9.

PMID:
23729200
[PubMed - indexed for MEDLINE]
11.

Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin.

Stoetzer OJ, Fersching DM, Salat C, Steinkohl O, Gabka CJ, Hamann U, Braun M, Feller AM, Heinemann V, Siegele B, Nagel D, Holdenrieder S.

Cancer Lett. 2013 Aug 9;336(1):140-8. doi: 10.1016/j.canlet.2013.04.013. Epub 2013 Apr 21.

PMID:
23612068
[PubMed - indexed for MEDLINE]
12.

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer.

Boeck S, Wittwer C, Heinemann V, Haas M, Kern C, Stieber P, Nagel D, Holdenrieder S.

Br J Cancer. 2013 Apr 30;108(8):1684-94. doi: 10.1038/bjc.2013.158. Epub 2013 Apr 11.

PMID:
23579210
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.

Haas M, Heinemann V, Kullmann F, Laubender RP, Klose C, Bruns CJ, Holdenrieder S, Modest DP, Schulz C, Boeck S.

J Cancer Res Clin Oncol. 2013 Apr;139(4):681-9. doi: 10.1007/s00432-012-1371-3. Epub 2013 Jan 13.

PMID:
23315099
[PubMed - indexed for MEDLINE]
14.

Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapy.

Zeiss K, Parhofer KG, Heinemann V, Haas M, Laubender RP, Holdenrieder S, Schulz C, Boeck S.

Anticancer Res. 2013 Jan;33(1):287-92.

PMID:
23267159
[PubMed - indexed for MEDLINE]
15.

Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?

Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J.

World J Urol. 2014 Apr;32(2):353-8. doi: 10.1007/s00345-012-1010-2. Epub 2012 Dec 25.

PMID:
23266581
[PubMed - in process]
16.

DNase is a prognostic marker in liver cancer patients receiving transarterial chemoembolization therapy.

Kohles N, Nagel D, Jüngst D, Stieber P, Holdenrieder S.

Int J Clin Pharmacol Ther. 2013 Jan;51(1):80-3. No abstract available.

PMID:
23260008
[PubMed - indexed for MEDLINE]
Free Article
17.

Soluble receptor of advanced glycation end products (sRAGE) indicates response to chemotherapy in pancreatic cancer patients.

Wittwer C, Boeck S, Heinemann V, Haas M, Stieber P, Nagel D, Holdenrieder S.

Int J Clin Pharmacol Ther. 2013 Jan;51(1):67-9. No abstract available.

PMID:
23260004
[PubMed - indexed for MEDLINE]
Free Article
18.

CA 15-3 is a predictive and prognostic biomarker in patients with metastasized breast cancer undergoing Selective Internal Radiation Therapy.

Fahmueller YN, Nagel D, Hoffmann RT, Tatsch K, Jakobs T, Stieber P, Holdenrieder S.

Int J Clin Pharmacol Ther. 2013 Jan;51(1):63-6. No abstract available.

PMID:
23260003
[PubMed - indexed for MEDLINE]
Free Article
19.

Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer.

Lehner J, Stötzer OJ, Fersching DM, Nagel D, Holdenrieder S.

Int J Clin Pharmacol Ther. 2013 Jan;51(1):59-62. No abstract available.

PMID:
23260002
[PubMed - indexed for MEDLINE]
Free Article
20.

Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer.

Gezer U, Ustek D, Yörüker EE, Cakiris A, Abaci N, Leszinski G, Dalay N, Holdenrieder S.

Tumour Biol. 2013 Feb;34(1):329-36. doi: 10.1007/s13277-012-0554-5. Epub 2012 Oct 20.

PMID:
23086575
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk